Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes

Affiliations

• ¹ Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY, USA.
• ² Princess Margaret Cancer Center, Toronto, ON, Canada.
• ³ Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, USA.
• ⁴ MD Anderson Cancer Center, Houston, TX, USA.
• ⁵ MD Anderson Cancer Center, Madrid, Spain.
• ⁶ Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain.
• ⁷ GSK, Collegeville, PA, USA.
• ⁸ Alfred Hospital and Monash University, Melbourne, VIC, Australia.